Patents by Inventor Michiel de Vries

Michiel de Vries has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination Therapy
    Publication number: 20230042959
    Abstract: This disclosure provides a dosage regimen for co-administration of enzalutamide and a strong CYP3A4 inducer.
    Type: Application
    Filed: October 4, 2022
    Publication date: February 9, 2023
    Inventors: Jacqueline Gibbons, Joyce Mordenti, Michiel De Vries, Walter Krauwinkel, Taoufik Ouatas
  • Combination Therapy
    Publication number: 20210069166
    Abstract: This disclosure provides a dosage regimen for co-administration of 4-[7-[6-cyano-5-(trifluoromethyl)pyridin-3-yl]-8-oxo-6-sulfanylidene-5,7-diazaspiro[3.4]octan-5-yl]-2-fluoro-N-methylbenzamide and a strong CYP3A4 inducer.
    Type: Application
    Filed: March 30, 2020
    Publication date: March 11, 2021
    Inventors: Jacqueline Gibbons, Joyce Mordenti, Michiel De Vries, Walter Krauwinkel, Taoufik Ouatas
  • Treatment of Cancer with Enzalutamide and a CYP3A4 Inhibitor
    Publication number: 20180235935
    Abstract: This disclosure provides a dosage regimen for co-administration of enzalutamide and a strong CYP3A4 inducer in the treatment of cancer.
    Type: Application
    Filed: August 11, 2016
    Publication date: August 23, 2018
    Inventors: Jacqueline GIBBONS, Joyce MORDENTI, Michiel DE VRIES, Walter KRAUWINKEL
  • Combination Therapy with Apalutamide
    Publication number: 20180228790
    Abstract: This disclosure provides a dosage regimen for co-administration of 4-[7-[6-cyano-5-(trifluoromethyl)pyridin-3-yl]-8-oxo-6-sulfanylidene-5,7-diazaspiro[3.4]octan-5-yl]-2-fluoro-N-methylbenzamide and a strong CYP3A4 inducer.
    Type: Application
    Filed: August 11, 2016
    Publication date: August 16, 2018
    Inventors: Jacqueline GIBBONS, Joyce MORDENTI, Michiel DE VRIES, Walter KRAUWINKEL
  • PHARMACEUTICAL COMPOSITIONS COMPRISING N-TRIAZOLYMETHYL-PIPERAZINE COMPOUNDS AND METHODS OF USING SAME
    Publication number: 20070082905
    Abstract: The present invention relates to N-triazolylmethyl-piperazine compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compositions in treating and preventing diseases and disorders.
    Type: Application
    Filed: May 22, 2006
    Publication date: April 12, 2007
    Inventors: Michiel De Vries, Marianne de Bruijn
  • Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
    Publication number: 20060194812
    Abstract: The present disclosure provides novel pharmaceutical compounds and methods for making the same, novel pharmaceutical dosage forms and methods for making the same, and methods for using said compounds and dosage forms to treat and prevent diseases and/or disorders.
    Type: Application
    Filed: February 16, 2006
    Publication date: August 31, 2006
    Inventors: Irene Eijgendaal, Gerrit Klein, Maria Terhorst-Van Amstel, Klaas Zwier, Nico Bruins, Hendrikus Rigter, Eric Gout, Caroline Boon, Michiel De Vries
  • Extended release formulation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one
    Publication number: 20060013874
    Abstract: The present invention relates to an extended release formulation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one or a pharmaceutically acceptable salt thereof or a hydrate of said pharmaceutically acceptable salt thereof. The invention further relates to the preparation of these extended release formulations and their use in the prevention or treatment of disorders, especially pain and CNS disorders such as depression, anxiety and movement disorders.
    Type: Application
    Filed: July 12, 2005
    Publication date: January 19, 2006
    Inventors: Nico Bruins, Henderik Frijlink, Michiel de Vries
  • Liquid pharmaceutical formulations containing 3.7-diazabicyclo[3,3,1]nonane compounds and methods of treatment relating to arrhythmic events
    Publication number: 20050261300
    Abstract: A method of using 3,7-diazabicyclo[3,3,1]nonane compounds, preferably of 9,9-alkylene-3,7-diazabicyclo[3,3,1]nonane compounds, and most preferably to the use of tedisamil, and the physiologically acceptable acid addition salts and/or solvates thereof, in the form of a liquid pharmaceutical preparation for the treatment and/or inhibition of arrhythmic events in human patients, preferably in conversion of recent onset of atrial fibrillation or flutter to normal sinus rhythm in humans, as well as related methods and pharmaceutical products or packages.
    Type: Application
    Filed: July 13, 2005
    Publication date: November 24, 2005
    Applicant: Solvay Pharmaceuticals GmbH
    Inventors: Matthias Straub, Johannes Wilhelmus Catharine Maria Jansen, Michiel de Vries, Claus Steinborn, Werner Cautreels